Edition:
United States

Valeant Pharmaceuticals International Inc (VRX.TO)

VRX.TO on Toronto Stock Exchange

18.18CAD
17 Aug 2017
Change (% chg)

$0.29 (+1.62%)
Prev Close
$17.89
Open
$17.97
Day's High
$18.79
Day's Low
$17.97
Volume
1,908,608
Avg. Vol
1,457,011
52-wk High
$42.25
52-wk Low
$11.20

VRX.TO

Chart for VRX.TO

About

Valeant Pharmaceuticals International, Inc. is a pharmaceutical and medical device company. The Company is engaged in developing and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment,... (more)

Overall

Beta: -0.36
Market Cap(Mil.): $4,926.06
Shares Outstanding(Mil.): 347.33
Dividend: --
Yield (%): --

Financials

  VRX.TO Industry Sector
P/E (TTM): -- 31.64 32.84
EPS (TTM): -3.27 -- --
ROI: -2.83 15.30 14.86
ROE: -24.78 16.32 16.11

BRIEF-Valeant receives FDA confirmation of inspection for Tampa facility

* Valeant receives FDA confirmation of voluntary action indicated (VAI) inspection classification for tampa facility

Aug 16 2017

BRIEF-Paulson & Co dissolves share stake in Pfizer, ups in Valeant ‍​

* Paulson & Co dissolves share stake in Pfizer- SEC filing ‍​

Aug 14 2017

BRIEF-Hedge fund Paulson & Co trims stake in Valeant

Aug 10 Valeant Pharmaceuticals International Inc -

Aug 09 2017

Hedge fund Paulson & Co trims stake in Valeant

Aug 10 Valeant Pharmaceuticals International Inc investor John Paulson trimmed his stake in the Canadian drugmaker but said he remains fully supportive of the company's leadership.

Aug 09 2017

BRIEF-Paulson & Co reports 6 pct stake in Valeant, as of Aug 9

* Paulson & Co Inc reports 6 percent stake in Valeant as of Aug 9 - SEC filing

Aug 09 2017

BRIEF-Valeant says subsidiaries in Australia are under audit by tax office

* Says subsidiaries in australia are under audit by the australian tax office for various years beginning in 2010‍​

Aug 08 2017

Valeant says it will exceed debt repayment target, shares surge

Canada's Valeant Pharmaceuticals International Inc said on Tuesday it expects to repay more than $5 billion in debt earlier than it had targeted, news that pushed its shares up 9 percent.

Aug 08 2017

UPDATE 3-Valeant says it will exceed debt repayment target, shares surge

Aug 8 Canada's Valeant Pharmaceuticals International Inc said on Tuesday it expects to repay more than $5 billion in debt earlier than it had targeted, news that pushed its shares up 9 percent.

Aug 08 2017

CANADA STOCKS-TSX up on Valeant, Ritchie results; BlackBerry falls on sell rating

TORONTO, Aug 8 Canada's main stock index was modestly higher on Tuesday as positive earnings results and a deal in the gaming sector helped offset declines in BlackBerry Ltd and other tech shares.

Aug 08 2017

CANADA STOCKS-TSX opens higher; Valeant jumps

TORONTO, Aug 8 Canada's main stock index opened modestly higher on Tuesday, as better-than-expected quarterly results from Valeant Pharmaceuticals International Inc helped offset declines in tech stocks.

Aug 08 2017

Earnings vs. Estimates